SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-24-036720
Filing Date
2024-04-26
Accepted
2024-04-26 17:12:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea0204514-defa14a_unicycive.htm DEFA14A 25504
2 GRAPHIC image_001.jpg GRAPHIC 2986
  Complete submission text file 0001213900-24-036720.txt   30776
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40582 | Film No.: 24885192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)